Schering-Plough Products, LLC

Las Piedras, PR, United States

1

Total Recalls

0

Class I Recalls

0

Ongoing Recalls

Recalls by Schering-Plough Products, LLC

FDA Drug Class II Terminated

Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral Administration, Rx Only, Cytotoxic, NDC: 0085-1519-02, Schering Corporation, Kenilworth, New Jersey, 07033

December 12, 2012 Schering-Plough Products, LLC 17,169 Packages units